J A Double
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 5
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 3
- Oncology top 5%
- Cancer Treatment and Pharmacology 3
- Drug Transport and Resistance Mechanisms 2
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 4
- Biotechnology top 10%
- Cancer Research and Treatments 7
-
- Inflammatory mediators and NSAID effects 3
-
- Amino Acid Enzymes and Metabolism 2
- Co-authors
- Ian J. StratfordEric O. AboagyeStephen R. WedgeD J ChaplinGillian M. TozerJeffrey I. EverittVicky RobinsonPaul Workman
- Cited by
- ToxicologyCancer ResearchOncology
- Journals
- British Journal of Cancer (13 papers)JNCI Journal of the National Cancer Institute (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- United KingdomGermanyNorth Macedonia
In The Last Decade
J A Double
29 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Toxicology 86
- Cancer Research 374
- Oncology 523
- Molecular Biology 821
- Biotechnology 91
Countries citing papers authored by J A Double
This map shows the geographic impact of J A Double's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Double with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Double more than expected).
Fields of papers citing papers by J A Double
This network shows the impact of papers produced by J A Double. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Double. The network helps show where J A Double may publish in the future.
Co-authorship network
The 25 scholars most cited alongside J A Double, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the welfare and use of animals in cancer researchbreakdown → | 2010 | 1076 |
| 2 | Enhancement of the radio-and chemotherapy of murine tumours by AQ4N, a bioreductively activated anti-tumour agent. | 2000 | 4 |
| 3 | 1999 | 11 | |
| 4 | 1999 | 34 | |
| 5 | 1998 | 16 | |
| 6 | 1996 | 40 | |
| 7 | 1995 | 28 | |
| 8 | 1995 | 45 | |
| 9 | Methods for liquid chromatographic analysis of tamoxifen, tamoxifen metabolites and their geometric isomers in biological samples | 1993 | 1 |
| 10 | 1993 | 43 | |
| 11 | Anti-tumour activity and bone marrow toxicity of chloroethylnitrosocarbamoyl-amino acid derivatives. | 1992 | 1 |
| 12 | 1991 | 1 | |
| 13 | 1991 | 44 | |
| 14 | 1991 | 5 | |
| 15 | 1989 | 108 | |
| 16 | 1989 | 81 | |
| 17 | 1988 | 15 | |
| 18 | Experimental anti-tumor effects of flavone acetic acid (LM975). | 1988 | 5 |
| 19 | 1987 | 22 | |
| 20 | 1971 | 14 |
About J A Double
J A Double is a scholar working on Toxicology, Biotechnology and Pharmacology, having authored 29 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Research and Treatments (7 papers), Bioactive Compounds and Antitumor Agents (5 papers), Cancer therapeutics and mechanisms (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Treatment and Pharmacology (3 papers), Inflammatory mediators and NSAID effects (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Toxicology (86 citations), Cancer Research (374 citations) and Oncology (523 citations). J A Double has collaborated with scholars based in United Kingdom, Germany and North Macedonia. Frequent co-authors include Ian J. Stratford, Eric O. Aboagye, Stephen R. Wedge, D J Chaplin, Gillian M. Tozer, Jeffrey I. Everitt, Vicky Robinson, Paul Workman, M J Glennie and Sue Eccles. Their work appears in journals such as British Journal of Cancer, JNCI Journal of the National Cancer Institute, Journal of Medicinal Chemistry, Anti-Cancer Drugs and International Journal of Radiation Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.